COMMITMENTS AND CONTINGENCIES (Details Narrative)	12 Months Ended
Oct. 31, 2023 USD ($)
Research And Development Agreements [Member]
Other Commitments [Line Items]
Payments to acquire research and development	$ 3,500,000
Future payments over period	5 years
Agreement with Wistar Clevel and Clinic [Member]
Other Commitments [Line Items]
Legal license agreement	$ 70,000

The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

Name:	us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration